Unique ID issued by UMIN | UMIN000019820 |
---|---|
Receipt number | R000022898 |
Scientific Title | Efficacy of inhaled HYdrogen on neurological outcome following BRain Ischemia During post-cardiac arrest care (Phase II, multicenter, prospective, randomized, double-blinded, placebo-controlled trial) |
Date of disclosure of the study information | 2016/01/01 |
Last modified on | 2023/11/02 19:01:36 |
Efficacy of inhaled HYdrogen on neurological outcome following BRain Ischemia During post-cardiac arrest care (Phase II, multicenter, prospective, randomized, double-blinded, placebo-controlled trial)
HYBRID II trial
Efficacy of inhaled HYdrogen on neurological outcome following BRain Ischemia During post-cardiac arrest care (Phase II, multicenter, prospective, randomized, double-blinded, placebo-controlled trial)
HYBRID II trial
Japan |
post cardiac arrest syndrome
Medicine in general | Cardiology | Emergency medicine |
Intensive care medicine | Adult |
Others
NO
To test the efficacy and safety of hydrogen inhalation for patient with post cardiac arrest syndrome
Safety,Efficacy
Confirmatory
Pragmatic
Phase II
Rate of favorable neurological outcome (Cerebral Performance Category (CPC) 1 or 2) at 90 days
1. Survival rate at 90 days
2. Survival time during 90 days
3. Modified Rankin Scale (mRS), Glasgow coma scale (GCS), and Mini-Mental State Exam (MMSE) at 90 days
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
NO
NO
Institution is not considered as adjustment factor.
YES
Central registration
2
Treatment
Other |
2%hydrogen+oxygen
oxygen
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1. Age of 20 to 80 years.
2. Achieved return of spontaneous circulation irrespective of initial cardiac rhythm after out-of-hospital cardiac arrest.
3. Cardiac arrest of a presumed cardiac cause.
4. Sustained coma (Glasgow Coma Scale less than 8) on admission.
5. Systolic blood pressure equal to or greater than 80 mmHg irrespective of fluid loading, vasopressor and/or inotropic medication.
6. Informed consent obtained from patient's next of kin.
7. Possible to receive gas inhalation less than 6 hours after return of spontaneous circulation.
1. Known pre-arrest cerebral performance category (CPC) 3 or 4.
2. Known limitations in therapy and do not resuscitate order.
3. Cardiac arrest due to trauma, strangulation, intracranial hemorrhage, subarachnoid hemorrhage, cerebral infarction, acute aortic dissection, terminal cancer, or intoxication.
4. Oxygen saturation of less than 94% with 50% oxygen inhalation and adequate positive end-expiratory pressure.
5. Pregnancy.
6. Cardiopulmonary bypass use.
7. Determined as being inappropriate for the study by site investigators .
360
1st name | |
Middle name | |
Last name | Masaru Suzuki |
Keio University School of Medicine
Emergency and critical Care Medicine
35 Shinanomachi Shinjuku-ku Tokyo, Japan
+81-3-3225-1323
suzuki@a2.keio.jp
1st name | |
Middle name | |
Last name | Tomoyoshi Tamura |
Keio University School of Medicine
Emergency and critical Care Medicine
35 Shinanomachi Shinjuku-ku Tokyo, Japan
+81-3-3225-1323
tomoyoshitamura@keio.jp
Keio University School of Medicine, Department of Emergency and Critical Care Medicine
Taiyo Nippon Sanso Corporation
Profit organization
Japan
NO
2016 | Year | 01 | Month | 01 | Day |
Unpublished
Completed
2016 | Year | 09 | Month | 28 | Day |
2015 | Year | 11 | Month | 17 | Day |
2017 | Year | 02 | Month | 01 | Day |
2021 | Year | 12 | Month | 31 | Day |
2015 | Year | 11 | Month | 17 | Day |
2023 | Year | 11 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022898